Premium
Non‐coding RNAs as theranostics in human cancers
Author(s) -
Redis Roxana S.,
BerindanNeagoe Ioana,
Pop Victor I.,
Calin George A.
Publication year - 2012
Publication title -
journal of cellular biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 165
eISSN - 1097-4644
pISSN - 0730-2312
DOI - 10.1002/jcb.24038
Subject(s) - microrna , computational biology , non coding rna , personalized medicine , coding (social sciences) , bioinformatics , biology , gene , genetics , statistics , mathematics
Theranostics was coined originally as a term used to describe a system that combines diagnosis and therapy, aiming to provide the tools for personalized medicine. This review reasserts the grounds for regarding non‐coding RNAs (ncRNA) as theranostics in human cancers. The microRNAs (miRNAs) are the most well studied ncRNAs in recent years; their pivotal role in orchestrating tumor initiation and progression has been confirmed in all types of cancers. Hence, these small ncRNAs have emerged as attractive therapeutic targets and diagnostic tool. Various approaches to use their therapeutic potential have been taken, here we summarize the most important ones. In the near future, the focus of theranostics will be shifted towards longer and mechanistically more versatile ncRNAs, and we included some recent advances supporting this view. J. Cell. Biochem. 113: 1451–1459, 2012. © 2011 Wiley Periodicals, Inc.